AETHLON MEDICAL INC

Profile

Company Names

AETHLON MEDICAL INC

Addresses

11555 SORRENTO VALLEY ROAD, SUITE 203, SUITE 203, SAN DIEGO, CA 92121

9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO, CA 92123

9635 GRANITE RIDGE DRIVE, SAN DIEGO, CA 92123

8910 UNIVERSITY CENTER LANE #660, SAN DIEGO, CA 92122

8910 UNIVERSITY CENTER LANE, SUITE 660, SAN DIEGO, CA 92122

3030 BUNKER HILL STREET, SUITE 4000, SAN DIEGO, CA 92109

Phone Numbers

619-941-0360
858-459-7800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$25,686,473.00

Number of Funding Rounds:

18
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
18
2025-12-08 
$2,153,700.00 
$2,153,700.00 
$0.00 
Equity 
17
2020-01-22 
$2,733,797.00 
$2,733,797.00 
$0.00 
 
16
2015-06-25 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
15
2014-12-02 
$3,300,000.00 
$3,300,000.00 
$0.00 
Equity 
14
2014-11-06 
$527,780.00 
$527,780.00 
$0.00 
Debt 
13
2014-10-20 
$837,737.00 
$837,737.00 
$0.00 
Equity 
12
2014-07-29 
$838,725.00 
$838,725.00 
$0.00 
Equity 
11
2014-05-20 
$913,500.00 
$913,500.00 
$0.00 
Equity 
10
2013-10-30 
$1,795,900.00 
$2,000,000.00 
$204,100.00 
Equity 
9
2013-07-09 
$400,000.00 
$400,000.00 
$0.00 
Debt 
8
2012-06-19 
$2,037,834.00 
$5,000,000.00 
$2,962,166.00 
Equity 
7
2011-11-10 
$1,050,000.00 
$1,050,000.00 
$0.00 
Debt 
6
2011-04-01 
$350,000.00 
$350,000.00 
$0.00 
Debt 
5
2010-09-03 
$650,000.00 
$1,300,000.00 
$650,000.00 
Debt 
4
2010-07-15 
$890,000.00 
$890,000.00 
$0.00 
Debt 
3
2010-02-12 
$600,000.00 
$600,000.00 
$0.00 
Debt 
2
2009-08-24 
$307,500.00 
$307,500.00 
$0.00 
Debt 
1
2009-07-10 
$300,000.00 
$300,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLYN 
S. 
BARRY, JR. 
DIRECTOR
EDAWRD 
G. 
BROENNIMAN 
DIRECTOR
EDWARD 
G. 
BROENNIMAN 
DIRECTOR
GUY 
 
CIPRIANI 
DIRECTOR
CHARLES 
J. 
FISHER 
DIRECTOR
JAMES 
B. 
FRAKES 
EXECUTIVE OFFICER, DIRECTOR
NICOLAS 
 
GIKAKIS 
DIRECTOR
JAMES 
A. 
JOYCE 
EXECUTIVE OFFICER, DIRECTOR
RODNEY 
 
KENLEY 
EXECUTIVE OFFICER, DIRECTOR
RODNEY 
S. 
KENLEY 
EXECUTIVE OFFICER, DIRECTOR
SABRINA 
 
MARTUCCI JOHNSON 
DIRECTOR
TIMOTHY 
C. 
RODELL 
EXECUTIVE OFFICER, DIRECTOR
ANGELA 
 
ROSSETTI 
DIRECTOR
CHETAN 
S. 
SHAH 
DIRECTOR
CHETAN 
S. 
SHAH, M.D. 
DIRECTOR
CHETAN 
 
SHAH, MD 
DIRECTOR
CHETAN 
S. 
SHAH, MD 
DIRECTOR
RICHARD 
H. 
TULLIS 
DIRECTOR, EXECUTIVE OFFICER
RICHARD 
H. 
TULLIS, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
RICHARD 
H. 
TULLIS, PHD 
EXECUTIVE OFFICER, DIRECTOR
RICHARD 
H. 
TULLS, PHD 
EXECUTIVE OFFICER, DIRECTOR
PHILLIP 
 
WARD 
DIRECTOR
PHILLIP 
A. 
WARD 
DIRECTOR
THOMAS 
 
WORNHAM 
DIRECTOR
THOMAS 
V. 
WORNHAM 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2025-12-08 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2020-01-22 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2015-06-25 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2014-12-02 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Debt 
2014-11-06 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2014-10-20 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2014-05-20 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2014-07-29 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2013-10-30 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2013-10-30 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2013-10-30 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2013-10-30 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2012-06-19 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Debt 
2013-07-09 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2012-06-19 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2011-11-10 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2011-11-10 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2011-11-10 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2011-04-01 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2010-09-03 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2010-07-15 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2010-02-12 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2009-07-10 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NO REVENUES 
Debt 
2009-08-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
MAXIM GROUP, LLC
N/A
NONE
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
ROTH CAPITAL PARTNERS, LLC
ROTH CAPITAL PARTNERS, LLC
ROTH CAPITAL PARTNERS, LLC
ROTH CAPITAL PARTNERS, LLC
LAIDLAW + CO (UK) LTD.
LAIDLAW + CO (UK) LTD.
LAIDLAW + COMPANY (UK) LTD.
LAIDLAW + COMPANY (UK) LTD.